Research Article
The Correlation between PSCA Expression and Neuroendocrine Differentiation in Prostate Cancer
Table 4
Correlation among immunohistochemical markers in clinicopathological factors.
| Marker expression | PSA | PSCA | NSE |
| General preoperative PSA level | | | | PSA | | | | | NA | 0.087 | 0.055 | value | NA | 0.348 | 0.552 | PSCA | | | | | 0.087 | NA | 0.641a | value | 0.348 | NA | <0.001 | NSE | | | | | 0.055 | 0.64a | NA | value | 0.552 | <0.001 | NA | Preoperative | | | | PSA | | | | | NA | -0.361a | -0.372a | value | NA | 0.036 | 0.030 | PSCA | | | | | -0.361a | NA | 0.685a | value | 0.036 | NA | <0.001 | NSE | | | | | -0.372a | 0.685a | NA | value | 0.030 | <0.001 | NA | Patients with hormone therapy | | | | PSA | | | | | NA | 0.180 | 0.201 | value | NA | 0.333 | 0.279 | PSCA | | | | | 0.180 | NA | 0.587a | value | 0.333 | NA | 0.001 | NSE | | | | | 0.201 | 0.587a | NA | value | 0.279 | 0.001 | NA |
|
|
Abbreviations: PSA: prostate-specific antigen; PSCA: prostate stem cell antigen; NSE: enolase 2. aCorrelation is significant at the level (test of significance, Spearman correlation). |